Stephen A Harrison Selected Research

simtuzumab

1/2022	Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis.
12/2019	The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials.
10/2018	Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen A Harrison Research Topics

Disease

79	Non-alcoholic Fatty Liver Disease 10/2022 - 01/2002
71	Fibrosis (Cirrhosis) 04/2022 - 01/2003
24	Alcoholic Fatty Liver 01/2022 - 02/2006
22	Inflammation (Inflammations) 01/2022 - 01/2003
22	Insulin Resistance 12/2021 - 01/2002
19	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2016
16	Liver Diseases (Liver Disease) 04/2022 - 01/2004
13	Chronic Hepatitis C 08/2013 - 06/2005
12	Fatty Liver 01/2021 - 01/2003
11	Weight Loss (Weight Reduction) 01/2021 - 04/2003
10	Type 2 Diabetes Mellitus (MODY) 12/2021 - 01/2002
7	Infections 01/2020 - 10/2005
7	Obesity 01/2019 - 01/2002
7	Body Weight (Weight, Body) 07/2013 - 02/2006
6	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 02/2003
4	Pruritus (Itching) 01/2022 - 01/2020
4	Weight Gain 10/2021 - 10/2007
4	Anemia 10/2021 - 11/2010
3	Sclerosing Cholangitis 01/2022 - 01/2019
3	Disease Progression 01/2022 - 12/2019
3	Portal Hypertension 12/2021 - 01/2020
3	Nausea 10/2021 - 11/2019
3	Edema (Dropsy) 10/2021 - 11/2006
3	Fatigue 11/2020 - 11/2006
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2015 - 04/2006
3	Hepatitis C 03/2013 - 06/2008
3	Glucose Intolerance 10/2009 - 11/2006
2	Diarrhea 01/2022 - 10/2021
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2022 - 01/2018
2	Neoplasms (Cancer) 01/2021 - 12/2012
2	Cicatrix (Scar) 01/2020 - 01/2020

Drug/Important Bio-Agent (IBA)

22	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2006
13	Ribavirin (Virazole)FDA LinkGeneric 08/2013 - 06/2006
11	EnzymesIBA 10/2021 - 01/2003
10	Protons (Proton)IBA 04/2022 - 11/2018
10	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2022 - 03/2006
10	Alanine Transaminase (SGPT)IBA 12/2021 - 03/2006
9	Transaminases (Aminotransferases)IBA 01/2022 - 08/2004
9	Insulin (Novolin)FDA Link 01/2020 - 01/2002
9	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2003
8	aldaferminIBA 01/2022 - 01/2018
8	InterferonsIBA 08/2013 - 10/2005
7	nasIBA 10/2022 - 01/2018
7	Pharmaceutical PreparationsIBA 01/2022 - 08/2012
7	Pioglitazone (Actos)FDA Link 01/2016 - 02/2006
5	selonsertibIBA 01/2022 - 11/2019
5	Alkaline PhosphataseIBA 01/2022 - 08/2006
5	CollagenIBA 01/2022 - 10/2018
5	Complement C3 (C3 Complement)IBA 12/2021 - 01/2019
5	LipidsIBA 10/2021 - 07/2013
5	Antiviral Agents (Antivirals)IBA 01/2019 - 06/2005
5	Vitamin E FDA LinkGeneric 05/2016 - 11/2003
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2008
4	AdiponectinIBA 10/2015 - 01/2009
4	CytokinesIBA 10/2015 - 01/2003
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2014 - 06/2008
4	LDL Lipoproteins (beta Lipoproteins)IBA 03/2013 - 02/2006
3	resmetiromIBA 01/2022 - 11/2019
3	simtuzumabIBA 01/2022 - 10/2018
3	Collagen Type III (Type III Collagen)IBA 12/2021 - 01/2020
3	Keratin-18 (Keratin 18)IBA 12/2021 - 01/2011
3	Hormones (Hormone)IBA 06/2021 - 01/2019
3	Bile Acids and Salts (Bile Acids)IBA 06/2021 - 01/2019
3	oxidized low density lipoproteinIBA 01/2021 - 09/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2015 - 08/2008
3	2,4-thiazolidinedione (thiazolidinedione)IBA 02/2010 - 11/2006
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2022 - 01/2021
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 02/2006
2	BilirubinIBA 12/2021 - 05/2015
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 06/2021 - 01/2020
2	fibroblast growth factor 21IBA 01/2021 - 12/2019
2	semaglutideIBA 01/2021 - 10/2020
2	PegbelferminIBA 01/2021 - 12/2019
2	3- (2- (2- tert- butylphenylaminooxalyl)aminopropionylamino)- 4- oxo- 5- (2,3,5,6- tetrafluorophenoxy)pentanoic acidIBA 01/2020 - 01/2020
2	CaspasesIBA 01/2020 - 01/2020
2	cenicrivirocIBA 01/2020 - 01/2018
2	ORALIT (ORS)IBA 01/2019 - 01/2019
2	IronIBA 01/2018 - 05/2010
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2017 - 01/2002
2	AntioxidantsIBA 05/2016 - 02/2006
2	CreatinineIBA 01/2016 - 03/2013
2	LeptinIBA 10/2015 - 11/2012
2	Coffee FDA Link 04/2013 - 02/2012
2	peginterferon alfa-2b (Pegintron)FDA Link 03/2013 - 01/2010
2	RNA (Ribonucleic Acid)IBA 03/2013 - 12/2010
2	Hemoglobins (Hemoglobin)IBA 03/2013 - 08/2012
2	AdipokinesIBA 11/2012 - 08/2008
2	ThiazolidinedionesIBA 11/2011 - 02/2006
2	Rosiglitazone (Avandia)FDA Link 11/2011 - 02/2006
2	Nonesterified Fatty Acids (NEFA)IBA 10/2009 - 01/2003
2	Orlistat (Xenical)FDA Link 01/2009 - 04/2003

Therapy/Procedure

38	Therapeutics 01/2022 - 11/2002
11	Liver Transplantation 01/2022 - 11/2005
5	Drug Therapy (Chemotherapy) 01/2022 - 11/2008
4	Bariatric Surgery 01/2018 - 11/2007
3	Subcutaneous Injections 01/2021 - 10/2018
3	Glycemic Control 01/2021 - 11/2006
3	Diet Therapy (Therapy, Diet) 09/2012 - 04/2003
2	Transplantation 03/2015 - 08/2008
2	Drug Tapering 03/2013 - 11/2010